BE2014C053I2 - - Google Patents

Download PDF

Info

Publication number: BE2014C053I2
Authority: BE; Belgium

Application number

BE2014C053C

Other languages

French (fr)

Original Assignee

Otsuka Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-11

Filing date

2014-09-09

Publication date

2022-08-30

2014-09-09 Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd

2022-08-30 Publication of BE2014C053I2 publication Critical patent/BE2014C053I2/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/20—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

BE2014C053C 2002-10-11 2014-09-09 BE2014C053I2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2002298259		2002-10-11
PCT/JP2003/013070 WO2004033463A1 (en)	2002-10-11	2003-10-10	2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES

Publications (1)

Publication Number	Publication Date
BE2014C053I2 true BE2014C053I2 (en)	2022-08-30

Family

ID=32089299

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE2014C053C BE2014C053I2 (en)	2002-10-11	2014-09-09

Country Status (26)

Country	Link
US (1)	US7262212B2 (en)
EP (2)	EP1555267B1 (en)
JP (1)	JP4186065B2 (en)
KR (1)	KR100723847B1 (en)
CN (4)	CN100366624C (en)
AR (4)	AR041198A1 (en)
AU (1)	AU2003272979B2 (en)
BE (1)	BE2014C053I2 (en)
BR (1)	BRPI0314344B8 (en)
CA (1)	CA2497569C (en)
CY (2)	CY1113578T1 (en)
DK (1)	DK1555267T3 (en)
ES (1)	ES2400179T3 (en)
FR (1)	FR14C0066I2 (en)
HU (1)	HUS1400046I1 (en)
LU (1)	LU92517I2 (en)
MX (1)	MXPA05003674A (en)
MY (1)	MY139244A (en)
PL (3)	PL217919B1 (en)
PT (1)	PT1555267E (en)
RU (1)	RU2326121C3 (en)
SI (1)	SI1555267T1 (en)
TW (1)	TWI347946B (en)
UA (1)	UA83200C2 (en)
WO (1)	WO2004033463A1 (en)
ZA (1)	ZA200501033B (en)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4564713B2 (en)	2000-11-01	2010-10-20	ミレニアム・ファーマシューティカルズ・インコーポレイテッド	Nitrogen heterocyclic compounds, and methods for making nitrogen heterocyclic compounds and intermediates thereof
RU2324682C2 (en) *	2002-10-15	2008-05-20	Оцука Фармасьютикал Ко., Лтд.	1-substituted 4-nitroimidazole derivative and method of its production
ES2314460T3 (en) *	2003-10-31	2009-03-16	Otsuka Pharmaceutical Co., Ltd.	COMPOUNDS OF 2,3-DIHIDRO-6-NITROIMIDAZO (2,1-B) OXAZOL FOR THE TREATMENT OF TUBERCULOSIS.
JP4761756B2 (en) *	2003-10-31	2011-08-31	大塚製薬株式会社	2,3-Dihydroimidazo [2,1-b] oxazole compound
TWI300409B (en)	2004-02-18	2008-09-01	Otsuka Pharma Co Ltd	Method for producing 4-nitroimidazole compound
BRPI0509292B1 (en)	2004-03-31	2015-06-23	Nippon Soda Co	Cyclic Amine Compound and Composition
JP4787529B2 (en) *	2004-04-09	2011-10-05	大塚製薬株式会社	Pharmaceutical composition
JP4789966B2 (en) *	2004-04-09	2011-10-12	大塚製薬株式会社	Pharmaceutical composition
US7408066B2 (en) *	2005-06-20	2008-08-05	Schering Corproation	Carbon-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
SI1906926T1 (en) *	2005-07-28	2011-02-28	Otsuka Pharma Co Ltd	PHARMACEUTICAL COMPOSITION COMPRISING 2,3-DIHYDRO-6-NITROIMIDAZO?á2,1-B?åOXAZOLE DERIVATIVES
JP5105818B2 (en) *	2005-10-05	2012-12-26	大塚製薬株式会社	Pharmaceutical composition
TW201233389A (en) *	2005-10-05	2012-08-16	Otsuka Pharma Co Ltd	Antituberculous therapeutic drugs and kit containing the same
CN102936221B (en) *	2005-10-06	2014-09-10	日本曹达株式会社	Bridged cyclic amine compound and pest control agent
TW200800268A (en) *	2005-11-04	2008-01-01	Otsuka Pharma Co Ltd	Medicinal composition showing improved drug absorbability
AU2006333522A1 (en)	2005-12-21	2007-07-12	Decode Genetics, Ehf.	Biaryl nitrogen heterocycle inhibitors of LTA4H for treating inflammation
WO2007093557A1 (en) *	2006-02-13	2007-08-23	Laboratoires Serono S.A.	Sulfonamide derivatives for the treatment of bacterial infections
JP2007297305A (en) *	2006-04-28	2007-11-15	Daiso Co Ltd	Method for producing n-(2,3-epoxy-2-methylpropyl)phthalimide
JP5486928B2 (en) *	2007-02-26	2014-05-07	ヴァイティーファーマシューティカルズ，インコーポレイテッド	Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1
AR070301A1 (en) *	2007-05-08	2010-03-31	Otsuka Pharma Co Ltd	EPOXY COMPOUND AND METHOD TO PRODUCE THE SAME
EP2183229B1 (en) *	2007-07-26	2012-04-18	Vitae Pharmaceuticals, Inc.	Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
TW200922581A (en) *	2007-08-15	2009-06-01	Glaxo Group Ltd	Compounds
EP2205585A1 (en) *	2007-10-16	2010-07-14	Glaxo Group Limited	Quinoline derivatives used to treat inflammatory and allergic diseases
AR069207A1 (en) *	2007-11-07	2010-01-06	Vitae Pharmaceuticals Inc	CYCLIC UREAS AS INHIBITORS OF THE 11 BETA - HIDROXI-ESTEROIDE DESHIDROGENASA 1
WO2009075835A1 (en)	2007-12-11	2009-06-18	Vitae Pharmaceutical, Inc	CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
TW200934490A (en) *	2008-01-07	2009-08-16	Vitae Pharmaceuticals Inc	Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
WO2009094169A1 (en)	2008-01-24	2009-07-30	Vitae Pharmaceuticals, Inc.	Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2714532A1 (en) *	2008-02-11	2009-08-20	Vitae Pharmaceuticals, Inc.	1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
US8598160B2 (en) *	2008-02-15	2013-12-03	Vitae Pharmaceuticals, Inc.	Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
WO2009117109A1 (en) *	2008-03-18	2009-09-24	Vitae Pharmaceuticals, Inc.	Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
US7666864B2 (en) *	2008-03-26	2010-02-23	Global Alliance For Tb Drug Development	Bicyclic nitroimidazole-substituted phenyl oxazolidinones
ES2421537T3 (en)	2008-05-01	2013-09-03	Vitae Pharmaceuticals Inc	Cyclic 11beta-hydroxysteroid dehydrogenase 1 inhibitors
CA2723039A1 (en)	2008-05-01	2009-11-05	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2723034A1 (en)	2008-05-01	2009-11-05	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
JP5451752B2 (en) *	2008-05-01	2014-03-26	ヴァイティーファーマシューティカルズ，インコーポレイテッド	Cyclic inhibitor of 11β-hydroxysteroid dehydrogenase 1
US8846668B2 (en)	2008-07-25	2014-09-30	Vitae Pharmaceuticals, Inc.	Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
DK2324018T3 (en)	2008-07-25	2013-10-14	Boehringer Ingelheim Int	CYCLE INHIBITORS OF 11 BETA-HYDROXYSTEROID DEHYDROGENASE 1
US9643922B2 (en)	2008-08-18	2017-05-09	Yale University	MIF modulators
US9540322B2 (en)	2008-08-18	2017-01-10	Yale University	MIF modulators
CA2733554A1 (en) *	2008-08-18	2010-02-25	Yale University	Mif modulators
US8558005B2 (en)	2008-08-21	2013-10-15	Dynamit Nobel Gmbh Explosivstoff-Und Systemtechnik	Methods for the production of 2-halo-4-nitroimidazole and intermediates thereof
WO2010143007A1 (en) *	2009-06-10	2010-12-16	Dynamit Nobel Gmbh Explosivstoff-Und Systemtechnik	Method for the production of 2-halogeno-4-nitroimidazole
EP2393807B1 (en)	2009-02-04	2013-08-14	Boehringer Ingelheim International GmbH	Cyclic inhibitors of 11 -hydroxysteroid dehydrogenase 1
TW201039034A (en) *	2009-04-27	2010-11-01	Chunghwa Picture Tubes Ltd	Pixel structure and the method of forming the same
US8680093B2 (en)	2009-04-30	2014-03-25	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
KR20120061771A (en) *	2009-04-30	2012-06-13	비타이 파마슈티컬즈, 인코포레이티드	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2440537A1 (en)	2009-06-11	2012-04-18	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
WO2011002910A1 (en)	2009-07-01	2011-01-06	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
AU2010278779B2 (en) *	2009-07-31	2014-08-14	Global Alliance For Tb Drug Development	Nitroimidazooxazine and nitroimidazooxazole analogues and their uses
US9198913B2 (en)	2009-07-31	2015-12-01	Global Alliance For Tb Drug Development	Nitroimidazooxazines and their uses in anti-tubercular therapy
CA2769359C (en) *	2009-07-31	2017-03-07	Global Alliance For Tb Drug Development	Nitroimidazooxazines and their uses in anti-tubercular therapy
WO2011052522A1 (en)	2009-10-26	2011-05-05	富士フイルムＲｉファーマ株式会社	Diagnostic agent for infectious diseases
TW201200523A (en) *	2010-01-29	2012-01-01	Otsuka Pharma Co Ltd	Synthetic intermediate of oxazole compound and method for producing the same
GB201012209D0 (en) *	2010-05-31	2010-09-08	Ge Healthcare Ltd	In vivo imaging agent
WO2011159760A1 (en)	2010-06-16	2011-12-22	Vitae Pharmaceuticals, Inc.	Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
JP5813106B2 (en)	2010-06-25	2015-11-17	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Azaspirohexanone as an inhibitor of 11-β-HSD1 for the treatment of metabolic disorders
EA201300522A1 (en)	2010-11-02	2013-11-29	Бёрингер Ингельхайм Интернациональ Гмбх	PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF METABOLIC DISORDERS
CN103596960B (en)	2011-04-15	2016-11-16	大塚制药株式会社	6,7-Dihydroimidazo[2,1-B][1,3]oxazine fungicide
JP2015006994A (en) *	2011-10-28	2015-01-15	大正製薬株式会社	Dihydroimidazooxazole derivative
US9572809B2 (en)	2012-07-18	2017-02-21	Spero Trinem, Inc.	Combination therapy to treat Mycobacterium diseases
FR3000064A1 (en) *	2012-12-21	2014-06-27	Univ Lille Ii Droit & Sante	SPIROISOXAZOLINE-LIKE COMPOUNDS WITH POTENTIALIZING ACTIVITY OF AN ANTIBIOTIC COMPOSITION AND PHARMACEUTICAL PRODUCT COMPRISING SUCH COMPOUNDS
JP6532457B2 (en) *	2013-10-04	2019-06-19	カウンシルオブサイエンティフィックアンドインダストリアルリサーチ	6-Nitro-2,3-dihydroimidazo [2,1-b] oxazoles and processes for their preparation
CN103524492A (en) *	2013-10-23	2014-01-22	中国药科大学	Quinolones compound with side chain containing nitroimidazole group substitution as well as preparation and use thereof
TWI687409B (en)	2014-08-28	2020-03-11	日商大塚製藥股份有限公司	Fused heterocyclic compounds
JP6467042B2 (en) *	2014-10-21	2019-02-06	カウンシルオブサイエンティフィックアンドインダストリアルリサーチ	Substituted 1,2,3-triazol-1-yl-methyl-2,3-dihydro-2-methyl-6-nitroimidazo [2,1-b] oxazole as antimycobacterial agent and method for its preparation
CN105732659B (en) *	2014-12-12	2019-07-16	上海阳帆医药科技有限公司	Nitro glyoxaline compound and preparation method thereof and the purposes in pharmacy
TW201632533A (en) *	2015-01-29	2016-09-16	南京明德新藥研發股份有限公司	The nitroimidazole derivative for anti- tuberculosis uberculosis
KR102597449B1 (en) *	2015-03-27	2023-11-03	오츠카 세이야쿠 가부시키가이샤	Method for producing 1-(4-hydroxyphenyl)-4-(4-trifluoromethoxyphenoxy)piperidine or its salt
CN106317072B (en) *	2015-06-17	2020-03-17	盟科医药技术(上海)有限公司	Heterocyclic compounds for the treatment of mycobacterial infections and uses thereof
US10851079B2 (en)	2016-02-26	2020-12-01	Otsuka Pharmaceutical Co., Ltd.	Piperidine derivative
CN105859628B (en) *	2016-04-19	2018-08-07	清远职业技术学院	A kind of antimicrobial compound is to N imidazoles benzaldehyde contracting ortho-aminotoluene schiff bases and its preparation method and application
MX2019000858A (en) *	2016-07-22	2019-11-11	Medshine Discovery Inc	Crystal and salt of nitroimidazole, and manufacturing method thereof.
WO2019034700A1 (en) *	2017-08-16	2019-02-21	Glaxosmithkline Intellectual Property Development Limited	Novel compounds
EP3804720A4 (en)	2018-06-11	2022-02-09	Otsuka Pharmaceutical Co., Ltd.	Delamanid-containing composition
CN109705022A (en) *	2018-12-28	2019-05-03	上海彩迩文生化科技有限公司	A kind of preparation method of aromatic amine intermediate
CN112300192B (en) *	2019-08-02	2023-08-11	南京长澳医药科技有限公司	Nitroimidazole compound, preparation method and application thereof
CN110483549B (en) *	2019-08-30	2021-03-05	沈阳药科大学	Preparation method of nitroimidazole pyran antituberculosis drug
CN110615800A (en) *	2019-10-16	2019-12-27	李丽丽	Nitroimidazole compound and preparation method and application thereof
CN112156088B (en) *	2020-10-30	2021-08-31	健民药业集团股份有限公司	Application of compound in preparation of mycobacterium tuberculosis inhibitor
CN113603706A (en) *	2021-08-04	2021-11-05	深圳市泰力生物医药有限公司	Crystal form of delamasil, active drug and pharmaceutical composition containing the crystal form
JPWO2024024938A1 (en)	2022-07-29	2024-02-01
CN115368252B (en) *	2022-09-19	2024-01-12	西北农林科技大学	A 4-aminophenol derivative and its application
CN116640106B (en) *	2023-05-11	2024-03-08	郑州大学	A kind of phenylpiperazine compound and its preparation method and application
CN119059990B (en) *	2024-11-01	2025-02-07	安徽昊帆生物有限公司	Preparation method of 1-carbamic acid tert-butyl piperazine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5668127A (en)	1995-06-26	1997-09-16	Pathogenesis Corporation	Nitroimidazole antibacterial compounds and methods of use thereof

2003
- 2003-10-09 AR ARP030103673A patent/AR041198A1/en active IP Right Grant
- 2003-10-09 TW TW092128165A patent/TWI347946B/en not_active IP Right Cessation
- 2003-10-10 MY MYPI20033866A patent/MY139244A/en unknown
- 2003-10-10 EP EP03754085A patent/EP1555267B1/en not_active Expired - Lifetime
- 2003-10-10 BR BRPI0314344A patent/BRPI0314344B8/en not_active IP Right Cessation
- 2003-10-10 CN CNB2003801017508A patent/CN100366624C/en not_active Expired - Lifetime
- 2003-10-10 UA UAA200504391A patent/UA83200C2/en unknown
- 2003-10-10 SI SI200332254T patent/SI1555267T1/en unknown
- 2003-10-10 MX MXPA05003674A patent/MXPA05003674A/en active IP Right Grant
- 2003-10-10 AU AU2003272979A patent/AU2003272979B2/en not_active Expired
- 2003-10-10 PL PL376157A patent/PL217919B1/en unknown
- 2003-10-10 CN CNA2007100040367A patent/CN101172981A/en active Pending
- 2003-10-10 EP EP12193820.3A patent/EP2570418A3/en not_active Withdrawn
- 2003-10-10 US US10/530,429 patent/US7262212B2/en not_active Expired - Lifetime
- 2003-10-10 ES ES03754085T patent/ES2400179T3/en not_active Expired - Lifetime
- 2003-10-10 PL PL409525A patent/PL409525A1/en unknown
- 2003-10-10 WO PCT/JP2003/013070 patent/WO2004033463A1/en not_active Ceased
- 2003-10-10 PL PL404913A patent/PL404913A1/en unknown
- 2003-10-10 CA CA2497569A patent/CA2497569C/en not_active Expired - Lifetime
- 2003-10-10 PT PT37540853T patent/PT1555267E/en unknown
- 2003-10-10 KR KR1020057004567A patent/KR100723847B1/en not_active Expired - Lifetime
- 2003-10-10 CN CNA2007100040371A patent/CN101255170A/en active Pending
- 2003-10-10 CN CN201110416170.4A patent/CN102532162B/en not_active Expired - Lifetime
- 2003-10-10 DK DK03754085.3T patent/DK1555267T3/en active
- 2003-10-10 RU RU2005114017A patent/RU2326121C3/en active Protection Beyond IP Right Term
- 2003-10-14 JP JP2003353868A patent/JP4186065B2/en not_active Expired - Lifetime
2005
- 2005-02-03 ZA ZA200501033A patent/ZA200501033B/en unknown
2012
- 2012-04-23 AR ARP120101394A patent/AR086485A2/en unknown
2013
- 2013-01-25 CY CY20131100076T patent/CY1113578T1/en unknown
- 2013-02-08 AR ARP130100408A patent/AR089950A2/en unknown
- 2013-07-15 AR ARP130102514 patent/AR091771A2/en not_active Application Discontinuation
2014
- 2014-08-13 LU LU92517C patent/LU92517I2/en unknown
- 2014-08-14 HU HUS1400046C patent/HUS1400046I1/en unknown
- 2014-09-09 BE BE2014C053C patent/BE2014C053I2/fr unknown
- 2014-09-11 FR FR14C0066C patent/FR14C0066I2/en active Active
- 2014-09-24 CY CY2014041C patent/CY2014041I1/en unknown

Also Published As

Publication number	Publication date
EP2570418A2 (en)	2013-03-20
EP1555267A4 (en)	2010-08-18
WO2004033463A1 (en)	2004-04-22
US20060094767A1 (en)	2006-05-04
HK1171018A1 (en)	2013-03-15
BRPI0314344B1 (en)	2019-11-26
CN102532162A (en)	2012-07-04
DK1555267T3 (en)	2013-02-11
BRPI0314344B8 (en)	2021-05-25
EP2570418A3 (en)	2013-07-03
SI1555267T1 (en)	2013-05-31
RU2326121C2 (en)	2008-06-10
ES2400179T3 (en)	2013-04-08
ZA200501033B (en)	2006-06-28
AU2003272979B2 (en)	2009-07-23
AR086485A2 (en)	2013-12-18
CY1113578T1 (en)	2016-06-22
CN102532162B (en)	2015-05-27
US7262212B2 (en)	2007-08-28
JP4186065B2 (en)	2008-11-26
HUS1400046I1 (en)	2017-04-28
AR091771A2 (en)	2015-02-25
EP1555267A1 (en)	2005-07-20
CN101172981A (en)	2008-05-07
MY139244A (en)	2009-09-30
RU2005114017A (en)	2006-01-20
RU2326121C3 (en)	2021-09-17
CY2014041I2 (en)	2016-07-27
EP1555267B1 (en)	2013-01-16
CN100366624C (en)	2008-02-06
CY2014041I1 (en)	2016-07-27
HK1085463A1 (en)	2006-08-25
PL217919B1 (en)	2014-09-30
AR089950A2 (en)	2014-10-01
JP2004149527A (en)	2004-05-27
PL404913A1 (en)	2013-09-30
PL376157A1 (en)	2005-12-27
CN101255170A (en)	2008-09-03
CA2497569A1 (en)	2004-04-22
FR14C0066I1 (en)	2014-10-17
FR14C0066I2 (en)	2015-05-22
KR100723847B1 (en)	2007-05-31
LU92517I2 (en)	2014-10-13
TW200420568A (en)	2004-10-16
PL409525A1 (en)	2014-11-10
AU2003272979A1 (en)	2004-05-04
KR20050061473A (en)	2005-06-22
AR041198A1 (en)	2005-05-04
TWI347946B (en)	2011-09-01
UA83200C2 (en)	2008-06-25
PT1555267E (en)	2013-01-29
CN1705670A (en)	2005-12-07
MXPA05003674A (en)	2005-06-08
BR0314344A (en)	2005-07-12
CA2497569C (en)	2011-05-24

Publication	Publication Date	Title
BE2015C017I2 (en)	2022-09-22
FR14C0066I1 (en)	2014-10-17
BE2014C051I2 (en)	2022-08-09
BE2014C041I2 (en)	2022-08-09
BE2014C030I2 (en)	2022-08-09
BE2014C016I2 (en)	2023-03-07
BE2014C015I2 (en)	2022-08-09
BE2013C063I2 (en)	2023-03-07
BE2013C039I2 (en)	2023-03-07
JP2003177869A5 (en)	2005-11-10
BE2011C038I2 (en)	2022-08-09
BE2015C067I2 (en)	2024-08-08
ECSDI024326S (en)	2003-03-31
BE2013C046I2 (en)	2022-08-09
JP2003205916A5 (en)	2006-01-12
DE60228137D1 (en)	2008-09-18
JP2003205099A5 (en)	2005-07-21
JP2003052002A5 (en)	2008-08-28
JP2003094179A5 (en)	2007-01-25
JP2003083747A5 (en)	2005-09-08
JP2002204870A5 (en)	2007-01-11
DK200200281U3 (en)	2003-01-10
AU2002233037A1 (en)	2002-09-06
AU2001263071A1 (en)	2002-02-07
AU2002226740A1 (en)	2002-08-08